Cigna Corp (CI)
$218.90
1.88 (0.85%)
19:00 EST
CI Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
53.25B
PE Ratio
21.48
EPS
10.19
Volume (Avg. Vol.)
1.46M
Day's Range
216.43 - 220.06
52-Week Range
118.50 - 227.25
Dividend & Yield
0.04 (0.02%)
CI Stock Predictions, Articles, and Cigna Corp News
- From InvestorPlace
- From the Web
7 Elections Stocks You Definitely Want To Avoid Leading up To the Big Vote
Investors have these seven election stocks to consider avoiding, as uncertainties grow in the near-term and market selling rises.
5 Cheap Healthcare Stocks Making Money This Year
Health insurance stocks have made fat profits in 2020, but investors are ignoring analyst recommendations in fear of what may happen next year.
Why Evernorth May Not Resolve Cigna’s Long-Term Issues
Analysts are telling investors to buy Cigna stock, but there are reasons to question the long-term future of the health insurer.
4 Healthcare Stocks to Buy For Coronavirus Innovation
As the world and the markets continue to grapple with the effects of the novel coronavirus outbreak, these innovative healthcare stocks to buy look poised for success.
3 Big Stock Charts for Friday: United Technologies, Cigna, and Equifax
Friday's big stock charts feature names that have struggled but could now be in the buy zone.
Should Insider Buying Tempt You Into These 7 Stocks?
When considering these seven companies in 2020, should insider buying be one of your deciding factors? The answer just might be yes.
Stock Market Today: Tesla Scorches to New Highs; Buy Nike?
Tesla ripped to new highs and Nike's been named a Top Pick. Here's what else happened in the stock market today.
5 Insurance Stocks That Should Rise in 2020
These insurance stocks have the potential to deliver in 2020 as they will likely benefit from an improving labor makret and the Fed's decision to keep interest rates constant.
7 Sickly Healthcare Stocks to Avoid
The doctor is ordering you to protect your portfolio by avoiding these seven healthcare stocks. There are better investments elsewhere.
Healthcare Stocks: 1 Buy, 1 Sell, 1 Hold
You don't need to avoid healthcare stocks completely. Just be careful where you invest. There's one name Louis Navellier really likes in the space, for example.
10 Healthcare Stocks to Buy Despite the Headlines
Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.
Nasdaq Today: Biotech Wrecked; Buy Microsoft?
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
4 Top Stock Trades for Friday: CGC, MU, BBBY
Cigna, Bed Bath & Beyond, Micron and Canopy Growth were our top stock trades on Thursday as we go into Friday.
CVS Stock Has More Going for It Than Just a 3.69% Dividend Yield
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
Aetna Uncertainty Is Keeping CVS Stock Way Undervalued
It admittedly takes some guts to step into CVS stock here, in the middle of a renewed legal mess, but that's exactly the time to go bargain hunting.
7 Strong Buy Stocks with More Than Enough Upside
This rally looks like it still has room to run, and top analysts think these 7 "strong buy" stocks can surge higher.
5 Healthcare Stocks to Watch If America Chooses a Single-Payer System
With the Medicare for All Act threatening to impart a radical paradigm shift, healthcare stocks are suddenly under heavy fire.
There’s a Buy the Dip Opportunity in Walgreens Stock but It Isn’t Now
Walgreens stock tanked after the company reported weak second-quarter results and issued a light outlook, but there's opportunity here.
4 Sickly Healthcare Stocks to Avoid
These healthcare stocks have each hit a rough road for various reasons. Here's what investors need to know about each.
Cigna Earnings: CI Stock Takes a Hit on Poor Guidance
Cigna earnings for the fourth quarter of the year included poor 2019 guidance, sending CI stock falling on Friday.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
Sell